Home / Health / Skin Patch: Early Warning for Organ Rejection
Skin Patch: Early Warning for Organ Rejection
8 Apr
Summary
- A skin patch acts as a 'window' to detect organ rejection faster.
- The Sentinel trial is testing skin grafts to monitor transplant health.
- This method could lead to earlier treatment and prevent permanent damage.
A pioneering trial is using skin grafts as an early warning system for organ rejection. The Sentinel trial, led by Oxford experts, involves grafting a small patch of skin from the organ donor onto the recipient's forearm at the time of transplant.
This skin patch serves as a 'window' into the patient's transplant health. Researchers theorize that skin rejects earlier and more visibly than other organs. Therefore, any signs of rejection, such as a rash, can be detected quickly.
Darren White, a lung transplant recipient and one of 10 patients in the study, experienced a purple rash on his skin patch three months post-transplant. A biopsy confirmed mild rejection, and he was promptly treated with steroids.
White, who is now over a year post-transplant and doing well, believes this early detection method was crucial for his recovery. The trial, which aims to recruit 152 patients across five centers, is set to continue until 2027.
This innovative approach hopes to improve transplant outcomes, leading to better and longer lives for patients. It offers a significant advantage over traditional methods like blood tests and biopsies, which can be less immediate in detecting rejection.
